EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity
Johannes Lorenz Berg(Medical University of Graz), Armin Zebisch(Medical University of Graz), Andrea Berghold(Medical University of Graz), Carsten Müller‐Tidow(Heidelberg University), Michael Schuster(Austrian Academy of Sciences), Andreas Reinisch(Stem Cell Institute), Karl Kashofer(Medical University of Graz), Gudrun Pregartner(Medical University of Graz), Veronica Caraffini(Medical University of Graz), Thomas Penz(Austrian Academy of Sciences), Stefan Hatzl(Medical University of Graz), Albert Wölfler(Medical University of Graz), Heinz Sill(Medical University of Graz), Gerald Höefler(Medical University of Graz), Klaus Geißler(University of Vienna), Barbara Uhl(Medical University of Graz), Andreas Prokesch(Medical University of Graz), Bianca Perfler(Medical University of Graz)
Cited by 8
Related Papers
Ensembl 2012
|Nucleic Acids Research|2011|839
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Ensembl 2011
|Nucleic Acids Research|2010|600
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463